Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Opolon

Showing results (171-180 of 252) with videos related to

Pageof 26
Sort By:
Hepatology (Baltimore, Md.)|October 26, 1999
Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patientsY Benhamou, M Bochet, V Thibault, et al.
Alimentary Pharmacology & Therapeutics|August 6, 1998
Review article: Overview of medical treatments in unresectable hepatocellular carcinoma--an impossible meta-analysis?P Mathurin, O Rixe, N Carbonell, et al.
Oncogene|February 28, 2006
Pleiotrophin, a candidate gene for poor tumor vasculature and in vivo neuroblastoma sensitivity to irinotecanL Calvet, B Geoerger, M Regairaz, et al.
Journal of Hepatology|November 1, 1993
Grand mal seizures as a complication of treatment with pefloxacin in patients with cirrhosis. A report of three casesL Chapuis, J F Cadranel, P Nordmann, et al.
Journal of Hepatology|May 5, 1998
Pattern of HCV antibodies with special reference to NS5A reactivity in HCV-infected patients: relation to viral genotype, cryoglobulinemia and response to interferonL Frangeul, P Cresta, M Perrin, et al.
The Journal of Rheumatology|February 7, 1998
Anticardiolipin, anti-beta2-glycoprotein I, and antinucleosome antibodies in hepatitis C virus infection and mixed cryoglobulinemia. Multivirc GroupP Cacoub, L Musset, Z Amoura, et al.
Digestion|January 1, 1996
The use of new somatostatin analogues, lanreotide and octastatin, in neuroendocrine gastro-intestinal tumoursB Eriksson, E T Janson, N D Bax, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1990
Protein F. A novel F(ab)-binding factor, present in normal liver, and largely released in the digestive tract during hepatitisJ P Bouvet, R Pirès, F Lunel-Fabiani, et al.
Gene Therapy|August 24, 1999
Angiogenesis induced in muscle by a recombinant adenovirus expressing functional isoforms of basic fibroblast growth factorC Garcia-Martinez, P Opolon, V Trochon, et al.
Gene Therapy|October 7, 2005
The tumor suppressor activity induced by adenovirus-mediated BRCA1 overexpression is not restricted to breast cancersD Marot, P Opolon, S Brailly-Tabard, et al.
Pageof 26

Showing results (171-180 of 252) with videos related to

Sort By:
Pageof 26
Hepatology (Baltimore, Md.)|October 26, 1999
Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patientsY Benhamou, M Bochet, V Thibault, et al.
Alimentary Pharmacology & Therapeutics|August 6, 1998
Review article: Overview of medical treatments in unresectable hepatocellular carcinoma--an impossible meta-analysis?P Mathurin, O Rixe, N Carbonell, et al.
Oncogene|February 28, 2006
Pleiotrophin, a candidate gene for poor tumor vasculature and in vivo neuroblastoma sensitivity to irinotecanL Calvet, B Geoerger, M Regairaz, et al.
Journal of Hepatology|November 1, 1993
Grand mal seizures as a complication of treatment with pefloxacin in patients with cirrhosis. A report of three casesL Chapuis, J F Cadranel, P Nordmann, et al.
Journal of Hepatology|May 5, 1998
Pattern of HCV antibodies with special reference to NS5A reactivity in HCV-infected patients: relation to viral genotype, cryoglobulinemia and response to interferonL Frangeul, P Cresta, M Perrin, et al.
The Journal of Rheumatology|February 7, 1998
Anticardiolipin, anti-beta2-glycoprotein I, and antinucleosome antibodies in hepatitis C virus infection and mixed cryoglobulinemia. Multivirc GroupP Cacoub, L Musset, Z Amoura, et al.
Digestion|January 1, 1996
The use of new somatostatin analogues, lanreotide and octastatin, in neuroendocrine gastro-intestinal tumoursB Eriksson, E T Janson, N D Bax, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1990
Protein F. A novel F(ab)-binding factor, present in normal liver, and largely released in the digestive tract during hepatitisJ P Bouvet, R Pirès, F Lunel-Fabiani, et al.
Gene Therapy|August 24, 1999
Angiogenesis induced in muscle by a recombinant adenovirus expressing functional isoforms of basic fibroblast growth factorC Garcia-Martinez, P Opolon, V Trochon, et al.
Gene Therapy|October 7, 2005
The tumor suppressor activity induced by adenovirus-mediated BRCA1 overexpression is not restricted to breast cancersD Marot, P Opolon, S Brailly-Tabard, et al.
Pageof 26